Rojas Restrepo, J. L., Caballero Oteyza, A., Hübscher, K., Haberstroh, H., Fliegauf, M., Keller, B., Kobbe, R., Warnatz, K., Ehl, S., Proietti, M., & Grimbacher, B. (ca. 2022). Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study [Cd]. Universität. https://doi.org/10.3389/fimmu.2021.786516
Chicago Manual of Style 17th edition (author-date)Rojas Restrepo, Jessica L., Andrés Caballero Oteyza, Katrin Hübscher, Hanna Haberstroh, Manfred Fliegauf, Bärbel Keller, Robin Kobbe, Klaus Warnatz, Stephan Ehl, Michele Proietti, und Bodo Grimbacher. 2022. Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study. Cd. Freiburg: Universität. https://doi.org/10.3389/fimmu.2021.786516.
Springer - Basic (numeric, brackets)1. Rojas Restrepo JL, Caballero Oteyza A, Hübscher K, Haberstroh H, Fliegauf M, Keller B, Kobbe R, Warnatz K, Ehl S, Proietti M, Grimbacher B (2022) Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study. Universität, Freiburg
Interdisziplinäre Anthropologie (Deutsch)Rojas Restrepo, Jessica L. / Caballero Oteyza, Andrés / Hübscher, Katrin / Haberstroh, Hanna / Fliegauf, Manfred / Keller, Bärbel / Kobbe, Robin / Warnatz, Klaus / Ehl, Stephan / Proietti, Michele / Grimbacher, Bodo: Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study, Freiburg 2022.
Institut für Praxisforschung - Harvard (Bahr & Frackmann) (Deutsch)Rojas Restrepo, Jessica L.; Caballero Oteyza, Andrés; Hübscher, Katrin; Haberstroh, Hanna; Fliegauf, Manfred; Keller, Bärbel; Kobbe, Robin; Warnatz, Klaus; Ehl, Stephan; Proietti, Michele; Grimbacher, Bodo (2022): Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study, Freiburg: Universität, doi: 10.3389/fimmu.2021.786516.